Clinical Trial Update: Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two regimens of Crisaborole 2% ointment in Japanese participants aged 2+, assessing efficacy and safety for mild to moderate atopic der…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Crisaborole (crisaborole)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-14